StoneX Group Inc.
NASDAQ:SNEXFinancial - Capital Markets
+$0.76 today
- Market cap
- $6.49B
- Beta
- 0.66
- P/E (TTM)
- 21.9
- EPS (TTM)
- $6.04
Volume 0.87M
Average 0.96M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
StoneX Group Inc.
NASDAQ:SNEX
Intrinsic Alpha fair value
Locked
Current Price
$53.83
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +9.8% | +4.7% (4yr)1 analysts |
| Revenue | N/A | N/A | +26.1% | -53.8% (4yr)1 analysts |
| Net Income | N/A | N/A | +13.9% | +3.8% (4yr)1 analysts |
| EBIT | N/A | N/A | +11.6% | -30.6% (4yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +26.1% over three years. Forward estimates point to EPS at +4.7% (4yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Morgan Stanley NYSE:MS | $300.71B | $190.65 | Overvalued | 19.5 | +12.85% |
Houlihan Lokey, Inc. NYSE:HLI | $9.92B | $142.84 | Overvalued | 22.0 | -18.66% |
Jefferies Financial Group Inc. NYSE:JEF | $8.64B | $45.69 | Overvalued | 18.0 | -21.41% |
BGC Group, Inc NASDAQ:BGC | $5.17B | $11.10 | Overvalued | 32.2 | +32.98% |
Marex Group plc Ordinary Shares NASDAQ:MRX | $5.09B | $70.72 | Overvalued | 14.5 | +96.14% |
Piper Sandler Companies NYSE:PIPR | $4.65B | $66.23 | Overvalued | 19.7 | -18.08% |
Moelis & Company NYSE:MC | $4.14B | $56.00 | Overvalued | 22.2 | -9.25% |
Lazard Ltd NYSE:LAZ | $3.95B | $40.40 | Undervalued | 15.7 | -14.35% |
Perella Weinberg Partners NASDAQ:PWP | $1.07B | $13.26 | Overvalued | 56.3 | -25.92% |
Oppenheimer Holdings Inc. NYSE:OPY | $947.08M | $89.25 | Undervalued | 11.8 | +32.05% |
Continue the stock analysis
Jump to another research area for this company.